[IKT] QoQ Quarter Result on 31-Mar-2021 [#Q1]

Stock
[IKT] Inhibikase Therapeutics, Inc.
Announcement Date
17-May-2021
Financial Year
2021
Quarter
31-Mar-2021 [#Q1]
Profit Trend
QoQ- -118.29%
YoY- -382.08%
Quarter Report
IKT's Result
IKT's Financial Summary
View:
Show?
Quarter Result
31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 CAGR
Revenue 2 328 1,363 1,407 698 38 220 -95.60%
PBT -5,042 -4,471 -2,636 -2,637 -1,208 -671 -422 420.27%
Tax -0 -4,471 -2,628 -2,625 -2,841 -664 -414 -
NP -5,042 -4,471 -2,636 -2,637 -1,208 -671 -422 420.27%
Tax Rate - - - - - - - -
Total Cost 5,044 4,800 3,999 4,044 1,906 708 641 294.13%
Ratio Analysis
31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 CAGR
NP Margin -259,342.54 -1,361.26 -193.40 -187.40 -172.95 -1,779.72 -192.12 11954.95%
Per Share
31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 CAGR
EPS -1.20 -1.07 -1.29 -1.57 -0.87 -0.49 -0.31 145.92%
EPS Diluted -1.20 -1.07 -1.29 -1.57 -0.87 -0.49 -0.31 145.92%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.